Polymyxin B/Bacitracin

DEA Class; Rx

Common Brand Names; Ak-Poly-Bac, Polysporin Ophthalmic, Polycin

  • Antibiotics, Ophthalmic Combos

polymyxin B/bacitracin topical (OTC)

Brand and Other Names: Double Antibiotic Ointment, Polysporin
  • Classes: Antibacterials, Topical

Bacitracin; Polymyxin B is available in ophthalmic and topical forms. Polymyxin B is primarily active against gram-negative, aerobic bacteria, while bacitracin is effective against gram-positive bacteria.

Indication for the treatment of Ophthalmic Infection

Often used in blepharitis, conjunctivitis, and post-operative prophylaxis

Indicated for the Treatment of Prophylaxis Superficial Skin Infection

For gram-pos & gram-neg infections

Does not cause allergic contact dermatitis like neosporin or other neomycin containing topical antibiotic preparations

Minor ocular irritation; hypersensitivity to polymixin or product components

Hypersensitivity

Not for ophthalmic use or over large areas of body

Allergic contact dermatitis

Conjunctival erythema

Swelling

Itching

Burning

Allergic contact dermatitis

Ointment may blur vision

Not for injection into the eye

Never to be directly introduced into anterior chamber of the eye; ophthalmic ointments may retard corneal wound healing

Allergic cross-reactions may occur which could prevent the use of any or all of the antibiotics for treatment of future infections, including kanamycin, paromomycin, streptomycin, and possibly gentamicin

Not known whether therapy can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity; the drug should be given to a pregnant woman only if clearly needed

Not known whether drug is excreted in human milk; because many drugs are excreted in human milk, caution should be exercised when the drug is administered to a nursing woman

Adults

8 applications/day for up to 10 days for ophthalmic ointment; 3 applications/day for up to 7 days topically.

Elderly

8 applications/day for up to 10 days for ophthalmic ointment; 3 applications/day for up to 7 days topically.

Adolescents

Safety and efficacy have not been established.

Children

Safety and efficacy have not been established.

Infants

Safety and efficacy have not been established.

Polymyxin B / bacitracin ophthalmic

ointment

  • (polymyxin B 10,000units/bacitracin 500units)/g

Polymyxin B/bacitracin topical

topical ointment, cream

  • (10,000unit/500unit)/g

About the Author

You may also like these

0